Pleural involvement of dialysis-related amyloidosis

Masaru Suzuki1, Tomoko Betsuyaku, Tetsuya Kojima

  • 1Department of Respiratory Medicine, Kohnan Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Sapporo.

Insights

Dialysis-related amyloidosis (DRA) can affect the pleura, causing fluid buildup. This first report highlights DRA as a cause of pleural effusion in long-term dialysis patients.

Area of Science:

  • Nephrology
  • Pulmonology
  • Pathology

Background:

  • Dialysis-related amyloidosis (DRA) is a significant complication in patients undergoing long-term hemodialysis.
  • Beta2-microglobulin is the primary protein component of DRA.
  • Pleural involvement in DRA has been rarely documented.

Observation:

  • This report details two cases of pleural effusion in patients with long-term dialysis.
  • The pleural effusion was exudative in nature.
  • Beta2-microglobulin amyloid deposition in the pleura was observed.

Findings:

  • This study presents the first reported cases of pleural involvement of dialysis-related amyloidosis (DRA) manifesting as pleural effusion.
  • The findings confirm that beta2-microglobulin amyloid can deposit in the pleural space.
  • The pleural fluid analysis was consistent with exudative effusion.

Implications:

  • Pleural involvement of DRA should be considered in the differential diagnosis of exudative pleural effusion in long-term dialysis patients.
  • Early recognition and diagnosis of DRA-related pleural effusion may improve patient management.
  • Further research is warranted to understand the pathogenesis and treatment of pleural DRA.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...